1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Periodontal Disease Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Periodontal Disease Treatment Market, by Disease Type
8.1.1. Gingivitis
8.1.1.1. Market Revenue and Forecast
8.1.2. Chronic Periodontitis
8.1.2.1. Market Revenue and Forecast
8.1.3. Aggressive Periodontitis
8.1.3.1. Market Revenue and Forecast
8.1.4. Necrotizing Periodontal Diseases
8.1.4.1. Market Revenue and Forecast
8.1.5. Periodontal Abscess
8.1.5.1. Market Revenue and Forecast
9.1. Periodontal Disease Treatment Market, by Treatment Type
9.1.1. Non-Surgical Periodontal Therapy
9.1.1.1. Market Revenue and Forecast
9.1.2. Surgical Periodontal Therapy
9.1.2.1. Market Revenue and Forecast
9.1.3. Adjunctive Pharmacotherapy
9.1.3.1. Market Revenue and Forecast
9.1.4. Regenerative Therapy
9.1.4.1. Market Revenue and Forecast
10.1. Periodontal Disease Treatment Market, by Disease Severity
10.1.1. Mild
10.1.1.1. Market Revenue and Forecast
10.1.2. Moderate
10.1.2.1. Market Revenue and Forecast
10.1.3. Severe
10.1.3.1. Market Revenue and Forecast
11.1. Periodontal Disease Treatment Market, by End User
11.1.1. Dental Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast
11.1.3. Specialty Periodontal Centers
11.1.3.1. Market Revenue and Forecast
11.1.4. Academic and Research Institutes
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Disease Type
12.1.2. Market Revenue and Forecast, by Treatment Type
12.1.3. Market Revenue and Forecast, by Disease Severity
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Disease Type
12.1.5.2. Market Revenue and Forecast, by Treatment Type
12.1.5.3. Market Revenue and Forecast, by Disease Severity
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Disease Type
12.1.6.2. Market Revenue and Forecast, by Treatment Type
12.1.6.3. Market Revenue and Forecast, by Disease Severity
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Disease Type
12.2.2. Market Revenue and Forecast, by Treatment Type
12.2.3. Market Revenue and Forecast, by Disease Severity
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Disease Type
12.2.5.2. Market Revenue and Forecast, by Treatment Type
12.2.5.3. Market Revenue and Forecast, by Disease Severity
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Disease Type
12.2.6.2. Market Revenue and Forecast, by Treatment Type
12.2.6.3. Market Revenue and Forecast, by Disease Severity
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Disease Type
12.2.7.2. Market Revenue and Forecast, by Treatment Type
12.2.7.3. Market Revenue and Forecast, by Disease Severity
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Disease Type
12.2.8.2. Market Revenue and Forecast, by Treatment Type
12.2.8.3. Market Revenue and Forecast, by Disease Severity
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Disease Type
12.3.2. Market Revenue and Forecast, by Treatment Type
12.3.3. Market Revenue and Forecast, by Disease Severity
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Disease Type
12.3.5.2. Market Revenue and Forecast, by Treatment Type
12.3.5.3. Market Revenue and Forecast, by Disease Severity
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Disease Type
12.3.6.2. Market Revenue and Forecast, by Treatment Type
12.3.6.3. Market Revenue and Forecast, by Disease Severity
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Disease Type
12.3.7.2. Market Revenue and Forecast, by Treatment Type
12.3.7.3. Market Revenue and Forecast, by Disease Severity
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Disease Type
12.3.8.2. Market Revenue and Forecast, by Treatment Type
12.3.8.3. Market Revenue and Forecast, by Disease Severity
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Disease Type
12.4.2. Market Revenue and Forecast, by Treatment Type
12.4.3. Market Revenue and Forecast, by Disease Severity
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Disease Type
12.4.5.2. Market Revenue and Forecast, by Treatment Type
12.4.5.3. Market Revenue and Forecast, by Disease Severity
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Disease Type
12.4.6.2. Market Revenue and Forecast, by Treatment Type
12.4.6.3. Market Revenue and Forecast, by Disease Severity
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Disease Type
12.4.7.2. Market Revenue and Forecast, by Treatment Type
12.4.7.3. Market Revenue and Forecast, by Disease Severity
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Disease Type
12.4.8.2. Market Revenue and Forecast, by Treatment Type
12.4.8.3. Market Revenue and Forecast, by Disease Severity
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Disease Type
12.5.2. Market Revenue and Forecast, by Treatment Type
12.5.3. Market Revenue and Forecast, by Disease Severity
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Disease Type
12.5.5.2. Market Revenue and Forecast, by Treatment Type
12.5.5.3. Market Revenue and Forecast, by Disease Severity
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Disease Type
12.5.6.2. Market Revenue and Forecast, by Treatment Type
12.5.6.3. Market Revenue and Forecast, by Disease Severity
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Dentsply Sirona Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Institut Straumann AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Solventum Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Geistlich Pharma AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Zimmer Biomet Holdings, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. ZimVie Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Envista Holdings Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. COLTENE Holding AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sunstar Suisse S.A.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Septodont Holding
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
